The test, which examines 18 genes, was created especially to identify malignancies that require rapid treatment as opposed to those that grow slowly.
Prostate Cancer
Researchers made a substantial advancement in computational pathology and medical diagnostics by creating a machine-learning model to enhance prostate cancer biopsy evaluation.